These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12134432)

  • 1. [Dangerous postprandial glucose peaks. Risk for heart and blood vessels].
    MMW Fortschr Med; 2002 May; 144(21):58. PubMed ID: 12134432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Islands cells are not activated quickly enough. Risk of obstruction of blood vessels].
    MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of type 2 diabetes. Effective control of postprandial glucose surges].
    MMW Fortschr Med; 2001 Jul; 143(28-29):56-7. PubMed ID: 11499153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
    MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fasting blood glucose has little value. Postprandial glucose indicates risk].
    MMW Fortschr Med; 2001 Jan; 143(1-2):53. PubMed ID: 11216017
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metformin--its regimen and effects].
    Shiba T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():382-8. PubMed ID: 12387022
    [No Abstract]   [Full Text] [Related]  

  • 8. Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia.
    Iwase M; Iino K; Doi Y; Asano T; Iida M
    Diabetes Res Clin Pract; 2008 Dec; 82(3):e19-22. PubMed ID: 18849086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type 2 diabetes. Regulating insulin according to need].
    MMW Fortschr Med; 2001 Oct; 143(42):62. PubMed ID: 11697294
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
    Dashora UK; Sibal L; Ashwell SG; Home PD
    Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipid profile in patients with type 2 diabetes.
    Katsiki N; Kolovou G
    Curr Med Res Opin; 2014 Jan; 30(1):121. PubMed ID: 24024786
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
    Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
    Nakashima E
    Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar.
    Blackburn GL
    Health News; 2004 Aug; 10(8):4-5. PubMed ID: 15551454
    [No Abstract]   [Full Text] [Related]  

  • 15. Type 2 diabetes management.
    Nelson G
    Br J Community Nurs; 2002 Jan; 7(1):5. PubMed ID: 11823724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
    Ambavane V; Patil R; Ainapure SS
    J Postgrad Med; 2002; 48(3):246-8. PubMed ID: 12432213
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions.
    Schatz H; Schoppel K; Lehwalder D; Schandry R
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.